iotaMotion

Coming – February 25

A Transformative Opportunity In Robotic Surgery

Date and Time

February 25

–

12:00 PM ET / 9:00 AM PT

Details will be provided upon RSVP approval

About this Event

iotaMotion is a growth-stage medical technology company focused on advancing cochlear implant (CI) surgery. Fewer than 5% of eligible cochlear implant candidates currently receive treatment, despite more than 430 million people worldwide experiencing disabling hearing loss. iotaMotion makes CI surgery more accessible for all.

iotaMotion has pioneered a new standard of care by bringing robotic precision. Placing cochlear implants is delicate procedure that challenges even the most practiced surgeon. iotaMotion improves consistency and control during surgical insertion, with clinical evidence supporting and hearing preservation.

The iotaSOFT® Insertion System is the first and only FDA-cleared robotic-assisted cochlear implant platform commercially available in the United States, with growing adoption across academic and private clinic settings. By enabling ultra-slow, controlled insertion speeds as low as 0.1 mm/second – beyond human capability – iotaSOFT is designed to reduce insertion forces and trauma to the cochlea.

Clinical evidence from more than 1,300 procedures across nearly 40 centers demonstrates meaningfully higher rates of hearing preservation compared to manual techniques, with no increase in complications.

Join our online event with iotaMotion President and CEO, Mike Lobinsky, to hear how their platform is enabling market expansion by reducing patient hesitation and unlocking demand that has been structurally constrained for decades.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.